Key facts
- This page summarizes Peter S. Garcia's Form 4 filing for ALX ONCOLOGY HOLDINGS INC (ALXO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Aug 2024, 17:08.
Peter S. Garcia - 14 Aug 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- ALXO
- Reported as of
- 14 Aug 2024
- Net transaction value
- -$1,963
- SEC form
- 4
- Accepted by SEC
- 16 Aug 2024, 17:08:10 UTC
- Prior SEC filing
- 02 Jul 2024
- Next SEC filing
- 27 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Garcia
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter S. Garcia filed Form 4 for ALX ONCOLOGY HOLDINGS INC (ALXO) on 16 Aug 2024.
Change
- Previous filing in this sequence was filed on 02 Jul 2024.
- Current net transaction value: -$1,963.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALXO
transaction
Common Stock
Tax liability
- Transaction value
- $1,963
- Shares
- -761
- Change %
- -0.62%
- Price
- $2.58
- Shares after
- 121,516
- Date
- 14 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.